This product may contain aluminum and benzyl alcohol
Regulatory status will remain contingent on new data and prevailing evidence standards, as well as the absence of approved therapeutic uses to date
Growth hormone and liver mitochondria
Patients on Tirzepatide 15 mg weekly lost an average of 20.9% or 48.6 lb of their body weight after 72 weeks in the Zepbound Study 1 (NCT04184622) compared to placebo patients who lost an average of 3.1% or 7.2 lb
Xu J, Xu Z, Ge N, Wang C, Hu C, Chen Z, Ouyang J, Pei C
The senolytic properties of ES2 were initially demonstrated in an in vitro study, where its effects were tested on both proliferating and senescent A375 melanoma cells (senescence was induced by doxorubicin treatment) [128]